Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
David Henry MD
David Henry MD Advisory Board
Rafael Fonseca MD
Rafael Fonseca MD Editor-in-Chief
Jean-Yves Douillard MD, PhD
Jean-Yves Douillard MD, PhD Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · April 30, 2023

Cemiplimab Plus Chemotherapy vs Chemotherapy Alone in Patients With Advanced NSCLC

Journal of Thoracic Oncology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Rodrigo Fonseca MD

Journal of Thoracic Oncology
Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial
J Thorac Oncol 2023 Mar 29;[EPub Ahead of Print], T Makharadze, M Gogishvili, T Melkadze, A Baramidze, D Giorgadze, K Penkov, K Laktionov, G Nemsadze, M Nechaeva, I Rozhkova, E Kalinka, S Li, Y Li, M Kaul, RGW Quek, JF Pouliot, F Seebach, I Lowy, G Gullo, P Rietschel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated